According to Zhitong Finance App News, Shanghai Pharmaceutical (601607.SH) announced that the controlling shareholder of the company, Shanghai Industrial (Group) Co., Ltd., plans to increase its H share holdings through the Hong Kong Stock Exchange Limited system through centralized bidding within the next 12 months through the Hong Kong Stock Exchange Limited system, increasing its total holdings of 11 million shares to 22 million shares, no more than 1% of the company's voting shares. Shangshi International increased its holdings of the company's H shares by 800,000 on November 2, 2026. After the increase, Shangshi International held 375 million H shares of the company, accounting for 10.119% of the company's total share capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.